Tuesday, November 1, 2022
6:00PM – 7:00PM ET
Please note this TeleECHO program is 6:00PM Eastern, 5:00PM Central, 4:00PM Mountain and 3:00PM Pacific.
PROGRAM OVERVIEW
This live virtual activity provides an opportunity for community oncologists and advanced practice providers to interact with experts to quickly get up to speed on the latest advances in EGFR-mutated NSCLC. During this program, faculty will describe the prognostic and predictive roles of common EGFR-mutations and the high risk clinical and disease characteristics to be aware of in patients with NSCLC. Through a review of clinical trial data and recent guidelines updates, faculty will increase confidence in individualizing treatment that addresses the underlying molecular pathology of disease. Participants will be encouraged to share their own cases and engage with faculty throughout this activity. Innovative learning platforms and practice tools will reinforce incorporation of targeted treatments into practice to help improve outcomes for patients with EGFR-mutated NSCLC.
PRESENTING FACULTY
Edward B Garon, MD, MS
Associate Professor,
David Geffen School of Medicine,
University of California,
Los Angeles, CA
TARGET AUDIENCE
This activity is designed to meet the educational needs of global oncologists and other community-based healthcare practitioners who care for patients with lung cancer.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Describe the various molecular diagnostics of EGFR-mutated NSCLC and associated subtypes
- Assess the association between EGFR-mutated NSCLC subtypes with clinical presentation and outcomes
- Apply key genomic findings, including high risk markers in the choice of combination therapy in patients with EGFR-mutated, metastatic NSCLC to optimize outcomes
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with lung cancer.
CNE Credit: 1.0 ANCC Contact Hour.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hours of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at [email protected].
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
